Normal Cerebellar Development in S100B-Deficient Mice

[1]  A. Reichenbach,et al.  Purinergic neuron-glia interactions in sensory systems , 2014, Pflügers Archiv - European Journal of Physiology.

[2]  D. Zochodne,et al.  Receptor for advanced glycation end-products (RAGE) activates divergent signaling pathways to augment neurite outgrowth of adult sensory neurons , 2013, Experimental Neurology.

[3]  V. Arolt,et al.  S100B overexpression increases behavioral and neural plasticity in response to the social environment during adolescence. , 2013, Journal of psychiatric research.

[4]  F. Rossi,et al.  Origin, lineage and function of cerebellar glia , 2013, Progress in Neurobiology.

[5]  J. Ekberg,et al.  Spatial and developmental heterogeneity of calcium signaling in olfactory ensheathing cells , 2013, Glia.

[6]  R. Donato,et al.  S100B protein in tissue development, repair and regeneration. , 2013, World journal of biological chemistry.

[7]  Xiaotang Fan,et al.  Bergmann Glia Function in Granule Cell Migration During Cerebellum Development , 2013, Molecular Neurobiology.

[8]  R. Donato,et al.  Functions of S100 proteins. , 2012, Current molecular medicine.

[9]  Adam Possner,et al.  Cerebellum , 2012, Neurology.

[10]  B. Nilius,et al.  Temperature-dependent calcium-induced calcium release via InsP3 receptors in mouse olfactory ensheathing glial cells. , 2012, Cell calcium.

[11]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[12]  Nicholas C Spitzer,et al.  Calcium signaling in neuronal development. , 2011, Cold Spring Harbor perspectives in biology.

[13]  Maria Florencia Angelo,et al.  S100B alters neuronal survival and dendrite extension via RAGE‐mediated NF‐κB signaling , 2011, Journal of neurochemistry.

[14]  S. Itohara,et al.  Normal delay eyeblink conditioning in mice devoid of astrocytic S100B , 2011, Neuroscience Letters.

[15]  S. Subramony,et al.  Bergmann Glial S100B Activates Myo-inositol Monophosphatase 1 and Co-localizes to Purkinje Cell Vacuoles in SCA1 Transgenic Mice , 2009, The Cerebellum.

[16]  F. Brozzi,et al.  S100B's double life: intracellular regulator and extracellular signal. , 2009, Biochimica et biophysica acta.

[17]  F. Brozzi,et al.  S100B Protein Regulates Astrocyte Shape and Migration via Interaction with Src Kinase , 2009, Journal of Biological Chemistry.

[18]  R. Hellweg,et al.  Distinct regulation of brain-derived neurotrophic factor and noradrenaline in S100B knockout mice , 2008, Neuroscience Letters.

[19]  C. Dreyfus,et al.  Glutamate elicits release of BDNF from basal forebrain astrocytes in a process dependent on metabotropic receptors and the PLC pathway. , 2008, Neuron glia biology.

[20]  S. Dobrin,et al.  Candidate gene analysis of 21q22: Support for S100B as a susceptibility gene for bipolar affective disorder with psychosis , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[21]  J. Hugnot,et al.  Expression of S100B during embryonic development of the mouse cerebellum , 2007, BMC Developmental Biology.

[22]  C. Lohr,et al.  Regulation of Store-Operated Calcium Entry by Calcium-Independent Phospholipase A2 in Rat Cerebellar Astrocytes , 2006, The Journal of Neuroscience.

[23]  L. V. Van Eldik,et al.  Enhanced susceptibility of S‐100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human β‐amyloid , 2005, Glia.

[24]  A. Dunaevsky,et al.  Purkinje cell dendrites grow in alignment with Bergmann glia , 2005, Glia.

[25]  C. Lohr,et al.  Blockage of voltage‐gated calcium signaling impairs migration of glial cells in vivo , 2005, Glia.

[26]  E. Azmitia,et al.  Chronic gliosis induced by loss of S-100B: knockout mice have enhanced GFAP-immunoreactivity but blunted response to a serotonin challenge , 2005, Brain Research.

[27]  J. Kapfhammer,et al.  Cellular and molecular control of dendritic growth and development of cerebellar Purkinje cells. , 2004, Progress in histochemistry and cytochemistry.

[28]  H. Komuro,et al.  Recent advances in cerebellar granule cell migration , 2003, Cellular and Molecular Life Sciences CMLS.

[29]  J. Baudier,et al.  Monitoring of S100 homodimerization and heterodimeric interactions by the yeast two‐hybrid system , 2003, Microscopy research and technique.

[30]  V. Arolt,et al.  S100B in brain damage and neurodegeneration , 2003, Microscopy research and technique.

[31]  Masanori Osawa,et al.  The role of calcium-binding proteins in the control of transcription: structure to function. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[32]  S. Itohara,et al.  Normal development of serotonergic neurons in mice lacking S100B , 2002, Neuroscience Letters.

[33]  S. Itohara,et al.  Glial protein S100B modulates long-term neuronal synaptic plasticity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  E. Peskind,et al.  Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease , 2001, Neurochemistry International.

[35]  C. Gottfried,et al.  Immunocontent and secretion of S100B in astrocyte cultures from different brain regions in relation to morphology , 2000, FEBS letters.

[36]  J. Roder,et al.  Enhanced calcium transients in glial cells in neonatal cerebellar cultures derived from S100B null mice. , 2000, Experimental cell research.

[37]  F. Nicoletti,et al.  Activation of A1 adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S‐100β protein from cultured astrocytes , 1999, Glia.

[38]  E. Azmitia,et al.  Transgenic mice overexpressing the neurotrophic factor S-100β show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome , 1997, Brain Research.

[39]  Helmut Kettenmann,et al.  Calcium signalling in glial cells , 1996, Trends in Neurosciences.

[40]  D. Grunwald,et al.  Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S. Barger,et al.  Neurite extension and neuronal survival activities of recombinant S100 beta proteins that differ in the content and position of cysteine residues , 1989, The Journal of cell biology.

[42]  A. Reichenbach,et al.  Quantitative-morphometric aspects of bergmann glial (Golgi epithelial) cell development in rats , 1987, Anatomy and Embryology.

[43]  H. Heinsen.  Quantitative anatomical studies on the postnatal development of the cerebellum of the albino rat , 1977, Anatomy and Embryology.

[44]  Lianfeng Zhang,et al.  S100B transgenic mice develop features of Parkinson's disease. , 2011, Archives of medical research.

[45]  B. Bogerts,et al.  S100B protein in neurodegenerative disorders , 2011, Clinical chemistry and laboratory medicine.

[46]  M. Rothermundt,et al.  S100B in schizophrenia: an update. , 2009, General physiology and biophysics.

[47]  E. Azmitia,et al.  Transgenic mice overexpressing the neurotrophic factor S-100 beta show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome. , 1997, Brain research.

[48]  J. Roder,et al.  Overexpression of a calcium-binding protein, S100 beta, in astrocytes alters synaptic plasticity and impairs spatial learning in transgenic mice. , 1995, Learning & memory.

[49]  D. Marshak.  S100 beta as a neurotrophic factor. , 1990, Progress in brain research.